ProPhase Labs, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Outstanding Debt (Details)

Outstanding Debt (Details) shares in Millions															1 Months Ended	3 Months Ended
Outstanding Debt (Details) shares in Millions	Jan. 21, 2025 USD ($) payments	Jan. 16, 2025 USD ($) payments	Dec. 19, 2024 USD ($)	Nov. 21, 2024 shares	Nov. 05, 2024 USD ($) investor	Oct. 22, 2024 USD ($)	Sep. 16, 2024 USD ($)	Aug. 15, 2024 USD ($)	Aug. 02, 2024 USD ($)	Aug. 01, 2024 USD ($) wk	Jun. 28, 2024 USD ($)	Jun. 27, 2024 USD ($) wk	Feb. 16, 2024 USD ($)	Feb. 14, 2024 USD ($) payment	Jul. 31, 2024 USD ($)	Mar. 31, 2025 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($)	Aug. 31, 2023 USD ($)	Jan. 26, 2023 USD ($)
Short-Term Debt [Line Items]
Proceeds from issuance of note payable, net																$ 204,000	$ 2,460,000
Short-term debt																2,450,000		$ 3,207,000
Amortization of debt discount																372,000	140,000
Discount, current																418,000		$ 237,000
Repayments of notes																1,509,000	$ 185,000
ERC Claim and Risk Participation Agreement
Short-Term Debt [Line Items]
Employee retention credit receivable																			$ 2,200,000
1861 Acquisition LLC \| ERC Claim and Risk Participation Agreement
Short-Term Debt [Line Items]
Proceeds from sale of company rights, title and interest to employee retention credit							$ 1,900,000
Payments of issuance costs for sale of company rights, title and interest to employee retention credit							154,000
Employee retention credit receivable, amount transferred							$ 2,200,000
ERC claim approve or deny period							24 months
Percentage of impaired amount allowed to be put back to the company							85.00%
Interest rate percentage on impaired amount allowed to be put back to the company							10.00%
PMI Note
Short-Term Debt [Line Items]
Debt, face amount			$ 1,000,000.0
Interest rate (as a percent)			15.00%
Term note period			12 months
Collateralized Loan Agreement
Short-Term Debt [Line Items]
Interest rate (as a percent)				6.00%
Term note period				2 years
Number of common shares secured for loan (in shares) \| shares				6
Arranger fee (as a percent)				5.00%
Outstanding balance																500,000
2025 Term Note
Short-Term Debt [Line Items]
Debt, face amount						$ 500,000
Interest rate (as a percent)						15.00%
Term note period						12 months
Periodic payment interest						$ 6,250
Debt instrument, periodic payment terms, balloon payment to be paid						$ 506,250
ERC Claim \| 1861 Acquisition LLC \| ERC Claim and Risk Participation Agreement
Short-Term Debt [Line Items]
Outstanding balance																1,800,000
Debt discount																368,000
2024 Third Future Receipts Financing And Amended Third Furutre Receipts Financing Agreement \| Loans Payable
Short-Term Debt [Line Items]
Amortization of debt discount																74,000
2024 Third Future Receipts Financing \| Loans Payable
Short-Term Debt [Line Items]
Debt, face amount										$ 675,000
Proceeds from issuance of note payable, net									$ 500,000
Origination fee									17,500
Brokerage fee									$ 17,500
Number of periodic payments \| wk										32
Periodic payment										$ 21,094
Short-term debt	$ 169,000
Amended Third Future Receipts Financing Agreement \| Loans Payable
Short-Term Debt [Line Items]
Proceeds from issuance of note payable, net	370,000
Origination fee	18,500
Brokerage fee	$ 20,000
Number of periodic payments \| payments	28
Periodic payment	$ 18,368
Short-term debt	514,000															290,000
Net proceeds from short-term debt	$ 183,000
Discount, current																59,000
2024 Second Future Receipts Financing, Amended Second Future Receipts Financing Agreement and Second Amended Second Future Receipts Financing Agreement \| Loans Payable
Short-Term Debt [Line Items]
Amortization of debt discount																218,000
2024 Second Future Receipts Financing \| Loans Payable
Short-Term Debt [Line Items]
Debt, face amount												$ 1,900,000
Proceeds from issuance of note payable, net											$ 1,500,000
Origination fee											$ 42,000
Brokerage fee															$ 22,000
Number of periodic payments \| wk												32
Periodic payment												$ 60,718
Repayments of notes					$ 1,000,000.0
Amended Second Future Receipts Financing Agreement \| Loans Payable
Short-Term Debt [Line Items]
Debt, face amount					2,100,000
Proceeds from issuance of note payable, net					1,500,000
Origination fee					$ 35,000
Number of periodic payments \| investor					24
Periodic payment					$ 89,000
Short-term debt		$ 1,100,000
Net proceeds from short-term debt					$ 527,000
Second Amended Slate Financing Agreement \| Loans Payable
Short-Term Debt [Line Items]
Proceeds from issuance of note payable, net		1,100,000
Origination fee		$ 34,500
Number of periodic payments \| payments		25
Periodic payment		$ 59,500
Short-term debt		1,500,000														692,000
Net proceeds from short-term debt		59,500
Discount, current																89,000
2024 Future Receipts Financing \| Loans Payable
Short-Term Debt [Line Items]
Debt, face amount														$ 3,000,000.0
Proceeds from issuance of note payable, net													$ 2,500,000
Origination fee													$ 50,000
Number of periodic payments \| payment														12
Periodic payment														$ 247,000
Short-term debt																471,000
Amortization of debt discount																5,000
Discount, current																$ 6,000
Discount factor, period														6 months
2024 Future Receipts Financing \| Loans Payable \| Minimum
Short-Term Debt [Line Items]
Debt instrument, measurement input														1.075
2024 Future Receipts Financing \| Loans Payable \| Maximum \| Measurement Input, Discount Rate
Short-Term Debt [Line Items]
Debt instrument, measurement input														1.165
2024 Future Receipts Financing - Addendum, First Two Months \| Loans Payable
Short-Term Debt [Line Items]
Periodic payment														$ 185,000
2024 Future Receipts Financing - Addendum, Remaining Ten Months \| Loans Payable
Short-Term Debt [Line Items]
Periodic payment														$ 259,000
JXVII Note \| Unsecured Debt
Short-Term Debt [Line Items]
Debt, face amount								$ 10,000,000.0												$ 7,600,000
Debt instrument, increase in principal amount								2,400,000
Proceeds from issuance of long-term debt								2,300,000
Outstanding interest exchanged								$ 94,000
JXVII Note \| Unsecured Debt \| Discontinued Operations, Disposed of by Sale \| Pharmaloz
Short-Term Debt [Line Items]
Disposal group, including discontinued operation, long-term debt		$ 10,300,000
JXVII Note \| Unsecured Debt \| Letter Agreement
Short-Term Debt [Line Items]
Interest rate (as a percent)								15.00%												10.00%